2 months ago
NBIX
AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Top 5%
#235 out of 5232 analysts
Average Return
+15.41%
Win Rate
46%102 out of 222
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +658.28% | $5.13 | $38.90 | 2023-10-11 - 2024-10-11 | Buy |
Edgewise Therapeutics IncEWTX | +560.25% | $5.51 | $36.38 | 2023-11-09 - 2024-11-08 | Buy |
Dianthus Therapeutics IncDNTH | +348.83% | $18.84 | $84.56 | 2025-05-12 - 2026-04-01 | Buy |
Ovid Therapeutics IncOVID | +314.00% | $0.50 | $2.07 | 2025-03-11 - 2026-03-11 | Buy |
Dianthus Therapeutics IncDNTH | +291.96% | $21.90 | $85.84 | 2025-03-11 - 2026-03-11 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
2 years ago
ARDX
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pepgen IncPEPG | 14 | Buy | $5.00 | +187.36% | Maintains | 2 days ago |
Viridian Therapeutics IncVRDN | 10 | Buy | $37.00 | +93.21% | Maintains | 2 days ago |
Larimar Therapeutics IncLRMR | 6 | Buy | $13.00 | +177.78% | Maintains | 14 days ago |
Ovid Therapeutics IncOVID | 3 | Buy | $7.00 | +224.07% | Maintains | 14 days ago |
Stoke Therapeutics IncSTOK | 11 | Buy | $38.00 | +18.79% | Maintains | 16 days ago |
Alto Neuroscience IncANRO | 5 | Hold | $22.00 | -6.02% | Maintains | 17 days ago |
Edgewise Therapeutics IncEWTX | 12 | Buy | $32.00 | -3.44% | Reiterates | 17 days ago |
Xenon Pharmaceuticals IncXENE | 11 | Buy | $63.00 | +11.13% | Maintains | 18 days ago |
Maze Therapeutics IncMAZE | 3 | Buy | $58.00 | +99.66% | Maintains | 18 days ago |
Solid Biosciences IncSLDB | 5 | Buy | $17.00 | +130.35% | Maintains | 21 days ago |
Dianthus Therapeutics IncDNTH | 14 | Buy | $103.00 | +21.81% | Maintains | 21 days ago |
Jade Biosciences IncJBIO | 7 | Buy | $24.00 | +49.81% | Reiterates | 25 days ago |
Climb Bio IncCLYM | 2 | Buy | $14.00 | +101.44% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 14 | Hold | $18.00 | -55.43% | Maintains | a month ago |
Gossamer Bio IncGOSS | 7 | Hold | $1.00 | +173.97% | Downgrades | a month ago |
Ardelyx IncARDX | 16 | Buy | $19.00 | +210.97% | Reiterates | a month ago |
Praxis Precision Medicines IncPRAX | 12 | Sell | $130.00 | -59.28% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 14 | Hold | $25.00 | +16.71% | Reiterates | a month ago |
Neurocrine Biosciences IncNBIX | 11 | Buy | $151.00 | +13.91% | Maintains | 2 months ago |
Biogen IncBIIB | 17 | Hold | $187.00 | +1.75% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 10 | Buy | $30.00 | +52.44% | Maintains | 4 months ago |
Vera Therapeutics IncVERA | 9 | Hold | $33.00 | -18.52% | Maintains | 4 months ago |
Pharvaris NvPHVS | 8 | Buy | $30.00 | +1.87% | Maintains | 5 months ago |
Astria Therapeutics IncATXS | 10 | Hold | $13.00 | +3.34% | Downgrades | 6 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 7 months ago |
Travere Therapeutics IncTVTX | 12 | Buy | $32.00 | +1.85% | Maintains | 8 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $18.00 | +91.90% | Maintains | 9 months ago |
Vigil Neuroscience IncVIGL | 11 | Hold | $8.00 | -0.62% | Downgrades | 10 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $6.00 | N/A | Reiterates | a year ago |
Longboard Pharmaceuticals IncLBPH | 7 | Buy | $44.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 3 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Rallybio CorpRLYB | 4 | Buy | $88.00 | N/A | Maintains | 2 years ago |
Design Therapeutics IncDSGN | 5 | Hold | $5.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | N/A | Downgrades | 3 years ago |
Impel Pharmaceuticals IncIMPLQ | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | 4 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 7 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 7 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.